David Einhorn's position in Gain Therapeutics is currently worth $1.72 Million. That's 0.08% of their equity portfolio (33rd largest holding). The investor owns 3.26% of the outstanding Gain Therapeutics stock. The investor's estimated purchase price is $7.33 Million, resulting in a loss of 76%.